claim: in the lab, st.org researchers uncover origins of deadly inflammation caused by the novel coronavirus
evidence_1: researchers further concluded that existing drugs, remicade and gamifant, which are used to treat such inflammatory diseases as crohns disease and colitis prevented covid-19 complications in laboratory models.", "a team led by thirumala-devi kanneganti, phd, vice chair of the st. jude department of immunology, identified a previously unknown interaction between two messenger proteins that can unleash a cascade of inflammatory cell death, leading to tissue damage and multiple organ failure.")